Skip to main content
ALGORAE PHARMACEUTICALS LIMITED logo

ALGORAE PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · 1AI ISIN · AU0000296022 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,159 across all filing types
Latest filing 2019-10-15 Regulatory Filings
Country AU Australia
Listing ASX 1AI

About ALGORAE PHARMACEUTICALS LIMITED

https://algoraepharma.com/

Algorae Pharmaceuticals Limited is a biopharmaceutical company focused on the discovery and development of novel therapeutic solutions for complex medical conditions. The company leverages its proprietary artificial intelligence platform, AlgoraeOS, to streamline the drug discovery process and identify synergistic drug combinations. Its research pipeline primarily targets neurodegenerative diseases and other areas of high unmet clinical need. Key development programs include AI-116, a combination therapy aimed at treating dementia and Alzheimer's disease. By integrating advanced computational modeling with traditional pharmacological research, the company seeks to accelerate the transition of candidates from preclinical stages to clinical trials, optimizing therapeutic efficacy and safety profiles.

Recent filings

Filing Released Lang Actions
LCT extends cash runway with receipt from Vertex acquisition 2 pages 77.3KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 15 October 2019 from Living Cell Technologies Limited regarding receipt of cash from the acquisition of Semma Therapeutics by Vertex Pharmaceuticals. It references the company's 2018-2019 annual report but does not contain any financial statements or detailed financial data itself. The document is short (4771 characters) and serves as an update on cash receipt extending the company's cash runway. It is not a full financial report, audit, or earnings release. It is an announcement related to capital inflow from an acquisition event but does not detail financing activities like new fundraising or capital structure changes. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories such as Capital/Financing Update or Earnings Release.
2019-10-15 English
Notice of Annual General Meeting/Proxy Form 19 pages 2.7MB
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' for Living Cell Technologies Limited, detailing the date, time, and place of the AGM. It includes a letter from the Chairman, a list of resolutions to be voted on at the AGM, including adoption of the Remuneration Report, election and removal of directors, and approval of share options. The document also provides explanatory notes and voting exclusions related to the AGM. There is no actual financial data or detailed financial statements included; rather, it is a notice and agenda for the AGM with supporting information for shareholders to consider before the meeting. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting. The document is lengthy (15,000 characters) and comprehensive, consistent with an AGM notice and explanatory materials, not a full annual report or other filing type.
2019-10-03 English
Annual Report to shareholders 44 pages 2.7MB
Annual Report Classification · 100% confidence The document is titled '2018 - 2019 ANNUAL REPORT' and contains detailed sections typical of an annual report, including Chairman's and CEO's letters, Directors' report, Auditor's independence declaration, consolidated financial statements, notes to the financial statements, Directors' declaration, and Independent auditor's report. The content includes comprehensive financial data, corporate governance information, significant events during the year, and detailed discussion of clinical trials and company strategy. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2019
2019-10-03 English
Appendix 4G and Corporate Governance Statement 23 pages 325.2KB
Governance Information Classification · 100% confidence The document is an Appendix 4G filing related to corporate governance disclosures for Living Cell Technologies Limited for the financial year ended 30 June 2019. It references compliance with ASX Listing Rules 4.7.3 and 4.10.3, which require lodging a corporate governance statement alongside the annual report. The document includes detailed disclosures about adherence to the ASX Corporate Governance Council Principles and Recommendations, including board roles, nomination committees, diversity policies, and evaluation processes. It is not the annual report itself but a regulatory filing specifically focused on corporate governance disclosures. The document is lengthy (15,000 characters) and contains substantive governance information rather than just an announcement or a brief summary. Therefore, it fits best under the category of Governance Information (CGR).
2019-10-03 English
Becoming a substantial holder 8 pages 245.2KB
Regulatory Filings
2019-09-26 English
LCT to benefit from Semma Therapeutics acquisition by Vertex 2 pages 83.7KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 18 September 2019 regarding Living Cell Technologies Limited's shareholding in Semma Therapeutics and the anticipated acquisition of Semma Therapeutics by Vertex Pharmaceuticals. It discusses the value of shares held and the intention to vote in favor of the acquisition. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is a brief announcement about a corporate event (acquisition) and shareholder position, not a full report or detailed filing. It does not contain audit information, earnings data, or management discussion. The content fits best under Capital/Financing Update (CAP) as it relates to a financing/corporate transaction update involving shareholding and acquisition news.
2019-09-18 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.